Skip to content

Community-Led COVID-19 Testing Intervention to Address Mistrust

Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust - Study 2

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07166770
Enrollment
49
Registered
2025-09-10
Start date
2025-07-01
Completion date
2026-01-27
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Trust

Keywords

community-led, COVID-19, trust, vaccine hesitancy, peer mentor, community advisory board

Brief summary

The goal of this adapted intervention study is to assess how community-led group discussions about health-related topics may alter beliefs and intentions regarding healthcare recommendations, such as COVID-19 testing and vaccination.

Detailed description

Eligible participants were randomized to intervention or control group. Intervention group participants met virtually with other community member participants in small discussion groups once a week for 75 minutes over the course of 14 weeks. The online discussion groups were led by peer mentor facilitators and supported by a research team member. Discussion topics included current events and other health related topics. Control group participants did not meet in weekly discussion groups. At approximately the 0 weeks, 14 weeks, and 18 weeks time points, all participants answered online surveys about health related topics. At the 14 weeks and 18 weeks time points, all participants were asked to self-administer a COVID-19 test that investigators provide.

Interventions

Participants engage in weekly community-led small group discussions about health related topics

Sponsors

Old Dominion University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Participants randomly assigned to intervention or control group; repeated measure assessments at 0 weeks, 14 weeks, and 18 weeks

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * Resident of one of the 9 housing authority agencies * Willing to participate in Zoom meetings and complete online assessments at baseline, 14-week, and 18-week timepoints * Ability to read, speak, and understand English

Exclusion criteria

* May not have participated in Study 1

Design outcomes

Primary

MeasureTime frameDescription
Openness to COVID-19 Testing0 weeks, 14 weeks, 18 weeksThe COVID-19 Testing Openness Questionnaire is an 7-item self-report measure designed to assess participants' openness to getting tested for COVID-19. Each item is rated on a 5-point scale, from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging from 7 to 35. Higher scores indicate greater openness to COVID-19 testing.
COVID-19 Testing Efficacy0 weeks, 14 weeks, 18 weeksThe COVID-19 Testing Efficacy Scale is a 6-item self-report measure that will assess participants' perceived self- and response-efficacy related to COVID-19 testing. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 6 and 30. Higher scores indicate greater efficacy.
Trust in the Safety of the COVID-19 Vaccine0 weeks, 14 weeks, 18 weeksTrust in the safety of the COVID-19 vaccine was measured with one item which assessed participants' trust in the safety of the COVID-19 vaccine. The item is rated on a 5-point Likert scale. Higher scores indicate greater trust.
Trust in Efficacy of the COVID-19 Vaccine0 weeks, 14 weeks, 18 weeksTrust in the efficacy of the COVID-19 vaccine was measured with one item which assessed participants' perceptions of efficacy related to the COVID-19 vaccine, or trust that it works as intended. The item is rated on a 5-point Likert scale. Higher scores indicate greater trust.

Secondary

MeasureTime frameDescription
COVID-19 Vaccine Hesitancy0 weeks, 14 weeks, 18 weeksVaccine Hesitancy was assessed by an item that asked, "Overall, how hesitant about the COVID-19 vaccine would you consider yourself to be?." This question was adapted from the Parent Attitudes about Childhood Vaccines (PACV) survey. The item is scored on a 5-point Likert scale, ranging from "1 - not at all hesitant" to "5 = very hesitant" with higher scores indicating greater hesitancy.
Social Connectedness0 weeks, 14 weeks, 18 weeksThe Social Connectedness Scale Revised is a 20-item scale that measures a participant's feeling of connection with other people and their community. Each item is rated on a 6-point scale ranging from 1 "Strongly Disagree" to 6 "Strongly Agree," with the sum of scores ranging between 20 and 120. Higher scores indicate greater connectedness.
Health Literacy0 weeks, 14 weeks, 18 weeksThe Health Literacy Scale (HLS-14) for Adults is a 14-item scale adapted for use in the US that measures an individual's ability to understand, access, and apply health-related information. Each item is rated on a 5-point scale ranging from 1 "Strongly Disagree" to 5 "Strongly Agree," with the sum of scores ranging between 14 and 70. Higher scores indicate greater health literacy.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKelli J England, PhD

Old Dominion University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026